{"id":"https://openalex.org/W1663220150","doi":"https://doi.org/10.2147/tcrm.s55930","title":"Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox\u2013Gastaut syndrome","display_name":"Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox\u2013Gastaut syndrome","alternate_titles":[],"publication_year":2015,"publication_date":"2015-06-01","ids":{"openalex":"https://openalex.org/W1663220150","doi":"https://doi.org/10.2147/tcrm.s55930","mag":"1663220150","pmid":"https://pubmed.ncbi.nlm.nih.gov/26089675","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4467745"},"language":"en","primary_location":{"id":"doi:10.2147/tcrm.s55930","doi":"https://doi.org/10.2147/tcrm.s55930","is_oa":true,"landing_page_url":"https://doi.org/10.2147/tcrm.s55930","pdf_url":"https://www.dovepress.com/getfile.php?fileID=25389","source":{"id":"https://openalex.org/S204453222","display_name":"Therapeutics and Clinical Risk Management","issn_l":"1176-6336","issn":["1176-6336","1178-203X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutics and Clinical Risk Management","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1663220150"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=25389","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111588147","display_name":"Michele A. Faulkner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Michele Faulkner","raw_affiliation_strings":["Department of Pharmacy Practice, Creighton University School of Pharmacy, Omaha, NE, USA ; Department of Neurology, Creighton University School of Medicine, Omaha, NE, USA","Department of Pharmacy Practice, Creighton University School of Pharmacy, Omaha, NE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, Creighton University School of Pharmacy, Omaha, NE, USA ; Department of Neurology, Creighton University School of Medicine, Omaha, NE, USA","institution_ids":["https://openalex.org/I114493937"]},{"raw_affiliation_string":"Department of Pharmacy Practice, Creighton University School of Pharmacy, Omaha, NE, USA","institution_ids":["https://openalex.org/I114493937"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111588147"],"corresponding_institution_ids":["https://openalex.org/I114493937"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":0.288,"has_fulltext":true,"cited_by_count":18,"citation_normalized_percentile":{"value":0.24693746,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"11","issue":null,"first_page":"905","last_page":"905"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12267","display_name":"Diet and metabolism studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clobazam","display_name":"clobazam","score":1.0},{"id":"https://openalex.org/keywords/lennox-gastaut-syndrome","display_name":"Lennox-Gastaut syndrome","score":0.9990000128746033},{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.8399999737739563},{"id":"https://openalex.org/keywords/atonic-seizures","display_name":"atonic seizures","score":0.718999981880188},{"id":"https://openalex.org/keywords/drop-seizures","display_name":"drop seizures","score":0.7630000114440918},{"id":"https://openalex.org/keywords/antiepileptic-drug-efficacy","display_name":"antiepileptic drug efficacy","score":0.7360000014305115},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.843999981880188},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.9129999876022339},{"id":"https://openalex.org/keywords/drug-cost-effectiveness","display_name":"drug cost-effectiveness","score":0.6800000071525574},{"id":"https://openalex.org/keywords/partial-agonists","display_name":"partial agonists","score":0.5789999961853027}],"concepts":[{"id":"https://openalex.org/C2777907850","wikidata":"https://www.wikidata.org/wiki/Q412164","display_name":"Clobazam","level":3,"score":0.9907233715057373},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8493375778198242},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8489352464675903},{"id":"https://openalex.org/C2779307984","wikidata":"https://www.wikidata.org/wiki/Q1544884","display_name":"Lennox\u2013Gastaut syndrome","level":3,"score":0.7433672547340393},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.5430499911308289},{"id":"https://openalex.org/C2909738485","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anti-Anxiety Agents","level":3,"score":0.4891803562641144},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.4781852066516876},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4566963315010071},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.432582288980484},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41826292872428894},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.4141371548175812},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3693612813949585},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.34303411841392517},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.32547158002853394},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3132781982421875},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2175845503807068},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.2147/tcrm.s55930","doi":"https://doi.org/10.2147/tcrm.s55930","is_oa":true,"landing_page_url":"https://doi.org/10.2147/tcrm.s55930","pdf_url":"https://www.dovepress.com/getfile.php?fileID=25389","source":{"id":"https://openalex.org/S204453222","display_name":"Therapeutics and Clinical Risk Management","issn_l":"1176-6336","issn":["1176-6336","1178-203X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutics and Clinical Risk Management","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3434116","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4467745","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4467745","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4467745/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Clin Risk Manag","raw_type":"Text"},{"id":"pmid:26089675","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26089675","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutics and clinical risk management","raw_type":"Journal Article"},{"id":"pmh:oai:dovepress.com/22076","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/comprehensive-overview-efficacy-tolerability-and-cost-effectivene-peer-reviewed-article-TCRM","pdf_url":"https://www.dovepress.com/article/download/22076","source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Review"},{"id":"pmh:oai:doaj.org/article:a6ebe1cfa9ae4ce0ab17261ad0bb1198","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/a6ebe1cfa9ae4ce0ab17261ad0bb1198","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Therapeutics and Clinical Risk Management, Vol 2015, Iss default, Pp 905-914 (2015)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.2147/tcrm.s55930","doi":"https://doi.org/10.2147/tcrm.s55930","is_oa":true,"landing_page_url":"https://doi.org/10.2147/tcrm.s55930","pdf_url":"https://www.dovepress.com/getfile.php?fileID=25389","source":{"id":"https://openalex.org/S204453222","display_name":"Therapeutics and Clinical Risk Management","issn_l":"1176-6336","issn":["1176-6336","1178-203X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutics and Clinical Risk Management","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1663220150.pdf","grobid_xml":"https://content.openalex.org/works/W1663220150.grobid-xml"},"referenced_works_count":54,"referenced_works":["https://openalex.org/W12106092","https://openalex.org/W635630645","https://openalex.org/W1488295954","https://openalex.org/W1671458509","https://openalex.org/W1900264518","https://openalex.org/W1971871303","https://openalex.org/W1977664713","https://openalex.org/W1988938430","https://openalex.org/W1998000482","https://openalex.org/W2001619275","https://openalex.org/W2003957180","https://openalex.org/W2014212238","https://openalex.org/W2015342345","https://openalex.org/W2019073856","https://openalex.org/W2020497106","https://openalex.org/W2021896716","https://openalex.org/W2025392760","https://openalex.org/W2025735892","https://openalex.org/W2031056359","https://openalex.org/W2031553719","https://openalex.org/W2033929287","https://openalex.org/W2062567896","https://openalex.org/W2065130340","https://openalex.org/W2067493358","https://openalex.org/W2068518385","https://openalex.org/W2071284271","https://openalex.org/W2074273355","https://openalex.org/W2075094885","https://openalex.org/W2078196673","https://openalex.org/W2079526548","https://openalex.org/W2079794001","https://openalex.org/W2080962580","https://openalex.org/W2081354339","https://openalex.org/W2081380386","https://openalex.org/W2081465656","https://openalex.org/W2083623577","https://openalex.org/W2084917404","https://openalex.org/W2088147052","https://openalex.org/W2090654997","https://openalex.org/W2092423304","https://openalex.org/W2110804937","https://openalex.org/W2118686382","https://openalex.org/W2119240134","https://openalex.org/W2133016973","https://openalex.org/W2137728866","https://openalex.org/W2156196899","https://openalex.org/W2159241839","https://openalex.org/W2163194681","https://openalex.org/W2169966598","https://openalex.org/W2170536966","https://openalex.org/W2290301262","https://openalex.org/W2296601685","https://openalex.org/W4211087970","https://openalex.org/W6807755605"],"related_works":["https://openalex.org/W2153016680","https://openalex.org/W2322682319","https://openalex.org/W2615851217","https://openalex.org/W2021896716","https://openalex.org/W2169966598","https://openalex.org/W2035250071","https://openalex.org/W2383659930","https://openalex.org/W2020497106","https://openalex.org/W2966332834","https://openalex.org/W2090654997"],"abstract_inverted_index":{"Clobazam":[0,200],"is":[1,141],"the":[2,7,15,30,38,54,62,70,76,82,90,104,144,157,162,192,206],"newest":[3],"medication":[4,31],"approved":[5],"by":[6],"US":[8],"Food":[9],"and":[10,43,72,84,89],"Drug":[11],"Administration":[12],"(FDA)":[13],"for":[14,46,103,143,183,209],"treatment":[16,145,207],"of":[17,27,92,107,146,194],"Lennox-Gastaut":[18],"syndrome":[19],"(LGS)":[20],"in":[21,35,61,120,129],"patients":[22],"at":[23,69,81],"least":[24],"2":[25],"years":[26],"age,":[28],"although":[29],"has":[32,176],"been":[33,125],"available":[34],"countries":[36],"around":[37],"world":[39],"to":[40,100,111,127,161,169,178,187,190,205],"treat":[41],"epilepsy":[42],"anxiety":[44],"disorders":[45],"many":[47],"years.":[48],"Though":[49],"classified":[50],"as":[51,64,94],"a":[52,95,171,180,202],"benzodiazepine,":[53],"drug":[55,175],"differs":[56],"structurally":[57],"from":[58,132],"other":[59,112],"drugs":[60],"class":[63],"it":[65],"possesses":[66],"nitrogen":[67],"atoms":[68],"1":[71,83],"5":[73],"positions":[74],"within":[75],"heterocyclic":[77],"ring":[78],"rather":[79],"than":[80],"4":[85],"positions.":[86],"This":[87],"difference":[88],"classification":[91],"clobazam":[93,118,140],"partial":[96],"agonist":[97],"are":[98],"believed":[99],"be":[101,170,179],"responsible":[102],"decreased":[105],"incidence":[106],"sedative":[108],"effects":[109,165],"compared":[110],"benzodiazepines.":[113],"Adverse":[114],"events":[115],"associated":[116,148],"with":[117,149],"use":[119],"clinical":[121],"trials":[122],"have":[123,137],"generally":[124],"mild":[126],"moderate":[128],"nature.":[130],"Data":[131],"an":[133],"open-label":[134],"extension":[135],"trial":[136],"confirmed":[138],"that":[139,196],"efficacious":[142],"seizures":[147,153,195],"LGS,":[150],"particularly":[151,185],"atonic":[152],"(drop":[154],"seizures),":[155],"over":[156],"long":[158],"term.":[159],"Tolerance":[160],"drug's":[163],"antiepileptic":[164],"does":[166],"not":[167],"seem":[168],"common":[172],"occurrence.":[173],"The":[174],"proven":[177],"cost-effective":[181],"option":[182],"therapy,":[184],"due":[186],"its":[188],"ability":[189],"decrease":[191],"number":[193],"require":[197],"medical":[198],"treatment.":[199],"represents":[201],"welcome":[203],"addition":[204],"options":[208],"LGS.":[210]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1663220150","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
